PKO Investment Management Joint-Stock’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,000
Closed -$261K 212
2025
Q2
$261K Hold
30,000
0.03% 170
2025
Q1
$239K Buy
30,000
+5,000
+20% +$50.6K 0.03% 171
2024
Q4
$227K Sell
25,000
-25,000
-50% -$241K 0.03% 155
2024
Q3
$459K Hold
50,000
0.06% 142
2024
Q2
$489K Buy
+50,000
New +$610K 0.06% 146
2022
Q2
Sell
-6,500
Closed -$469K 127
2022
Q1
$469K Buy
+6,500
New +$468K 0.06% 107

Other funds holding TDOC

PKO Investment Management Joint-Stock's TDOC Position: Q3 2025 in Review

PKO Investment Management Joint-Stock sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 30,000 shares — an estimated $261K sold.

PKO Investment Management Joint-Stock first reported a position in TDOC in Q1 2022 and held it in 6 quarters. The position peaked at $489K in Q2 2024. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • PKO Investment Management Joint-Stock reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • PKO Investment Management Joint-Stock sold 30,000 Teladoc Health shares in Q3 2025, an estimated $261K.
  • PKO Investment Management Joint-Stock first reported a position in Teladoc Health in Q1 2022 and held it in 6 quarters.
  • PKO Investment Management Joint-Stock's Teladoc Health position peaked at $489K in Q2 2024.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on PKO Investment Management Joint-Stock's 13F filing for Q3 2025, filed 27 Oct 2025.